全文获取类型
收费全文 | 32223篇 |
免费 | 1876篇 |
国内免费 | 155篇 |
专业分类
耳鼻咽喉 | 321篇 |
儿科学 | 781篇 |
妇产科学 | 799篇 |
基础医学 | 4740篇 |
口腔科学 | 1884篇 |
临床医学 | 2723篇 |
内科学 | 7172篇 |
皮肤病学 | 981篇 |
神经病学 | 2794篇 |
特种医学 | 529篇 |
外科学 | 2592篇 |
综合类 | 128篇 |
一般理论 | 21篇 |
预防医学 | 3652篇 |
眼科学 | 523篇 |
药学 | 2569篇 |
中国医学 | 192篇 |
肿瘤学 | 1853篇 |
出版年
2024年 | 42篇 |
2023年 | 384篇 |
2022年 | 872篇 |
2021年 | 1534篇 |
2020年 | 869篇 |
2019年 | 1249篇 |
2018年 | 1515篇 |
2017年 | 1009篇 |
2016年 | 961篇 |
2015年 | 1196篇 |
2014年 | 1571篇 |
2013年 | 1934篇 |
2012年 | 2958篇 |
2011年 | 3115篇 |
2010年 | 1545篇 |
2009年 | 1303篇 |
2008年 | 2143篇 |
2007年 | 2079篇 |
2006年 | 1802篇 |
2005年 | 1580篇 |
2004年 | 1373篇 |
2003年 | 1150篇 |
2002年 | 1003篇 |
2001年 | 111篇 |
2000年 | 62篇 |
1999年 | 92篇 |
1998年 | 134篇 |
1997年 | 128篇 |
1996年 | 82篇 |
1995年 | 64篇 |
1994年 | 66篇 |
1993年 | 48篇 |
1992年 | 44篇 |
1991年 | 29篇 |
1990年 | 23篇 |
1989年 | 20篇 |
1988年 | 16篇 |
1987年 | 14篇 |
1986年 | 13篇 |
1985年 | 12篇 |
1984年 | 12篇 |
1983年 | 12篇 |
1982年 | 15篇 |
1981年 | 9篇 |
1980年 | 13篇 |
1978年 | 6篇 |
1976年 | 6篇 |
1975年 | 7篇 |
1973年 | 5篇 |
1972年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
Ana Teresa Timóteo Andreia Mamede Maria de Lurdes Ferreira José Serra José Alberto Oliveira Rui Cruz Ferreira Jorge Quininha 《Revista portuguesa de cardiologia》2007,26(2):135-143
BACKGROUND: Nitrate therapy can induce ischemic preconditioning with a consequent increase in tolerance to ischemia. In the context of acute coronary syndromes (ACS), nitrates may result in a different presentation. with greater protection. OBJECTIVES: To investigate in a population of patients with ACS whether previous chronic use of nitrates results in a different presentation of ACS. METHODS: We studied 287 patients (65 +/- 13 years, 66% male) admitted to our department in the first six months of 2005 with ACS (with and without ST-segment elevation). Of these, 8% were under nitrate therapy at the time of admission. In this group, 27% presented ACS without ST-segment elevation, while in the group without nitrates this value was 58% (p = 0.005). By univariate analysis, the use of nitrates was a predictor of the preferential occurrence of non-ST-segment elevation ACS (OR 0.27, 95% CI 0.10-0.71). After correction for the potential influence of variables (age, gender, previous revascularization and smoking) by multivariate logistic regression, nitrate therapy remained a borderline predictor of clinical presentation as non-ST-segment elevation ACS (OR 0.37, 95% CI 0.13-1.04, p = 0.059). CONCLUSIONS: Previous use of nitrates was associated with a tendency to present as non-ST-segment elevation ACS. This finding may be explained by the hypothesis that nitrates induce pharmacological preconditioning, reducing the transmural extent of myocardial infarction. 相似文献
42.
43.
44.
Ana Lucia Z. Rosso MD James P. Mattos MD PhD Sérgio A. P. Novis MD PhD 《Clinical autonomic research》1993,3(5):299-301
Acase of periodic sweating with multifocal dystonia is reported in a 60-year-old woman. At the age of 48 years, she presented with involuntary twisting of the lower face on the right. Six months later she noticed similar movements in the head and right arm. Four years later she began having attacks of generalized sweating over the whole face, anterior region of the trunk and both arms. The attacks occurred hourly each and every day. They lasted for about 10 min and were followed by voluntary urinary voiding. The biochemical and laboratory investigations showed no abnormalities except for the luteinizing hormone and follicle-stimulating hormone values that were below normal. The computerized tomography and magnetic resonance imaging scans revealed a suprasellar cyst. Clonazepam was introduced with partial improvement of the dystonic movements but not of the sweating attacks. The patient refused surgery. Acetazolamide was added and reduced the sweating attacks. We speculate that the periodic sweating may be related to cerebrospinal fluid production and cyst enlargement, hence the ability of acetazoleamide, which reduces cerebrospinal fluid production, to reduce attacks. 相似文献
45.
Cleide G. da Silva Ana Rúbia F. Bueno Patrícia F. Schuck Guilhian Leipnitz Csar A. J. Ribeiro Clvis M. D. Wannmacher Angela T. S. Wyse Moacir Wajner 《International journal of developmental neuroscience》2003,21(4):217-224
L-2-Hydroxyglutaric acid (LGA) is the biochemical hallmark of patients affected by the neurometabolic disorder known as L-2-hydroxyglutaric aciduria (LHGA). Although this disorder is predominantly characterized by severe neurological findings and pronounced cerebellum atrophy, the neurotoxic mechanisms of brain injury are virtually unknown. In the present study, we investigated the effect of LGA, at 0.25-5mM concentrations, on total creatine kinase (tCK) activity from cerebellum, cerebral cortex, cardiac muscle and skeletal muscle homogenates of 30-day-old Wistar rats. CK activity was measured also in the cytosolic (Cy-CK) and mitochondrial (Mi-CK) fractions from cerebellum. We verified that tCK activity was significantly inhibited by LGA in the cerebellum, but not in cerebral cortex, cardiac muscle and skeletal muscle. Furthermore, CK activity from the mitochondrial fraction was inhibited by LGA, whereas that from the cytosolic fraction of cerebellum was not affected by the acid. Kinetic studies revealed that the inhibitory effect of LGA on Mi-CK was non-competitive in relation to phosphocreatine. Finally, we verified that the inhibitory effect of LGA on tCK was fully prevented by pre-incubation of the homogenates with reduced glutathione (GSH), suggesting that this inhibition is possibly mediated by oxidation of essential thiol groups of the enzyme. Considering the importance of creatine kinase activity for energy homeostasis, our results suggest that the selective inhibition of this enzyme activity by increased levels of LGA could be possibly related to the cerebellar degeneration characteristically found in patients affected by L-2-hydroxyglutaric aciduria. 相似文献
46.
Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography 总被引:3,自引:1,他引:2
Albert Flotats Ignasi Carrió Montserrat Estorch Lluís Bernà Ana M. Catafau Carina Mart Manel Ballester 《European journal of nuclear medicine and molecular imaging》1997,24(7):767-773
A comparison was performed between technetium-99m tetrofosmin myocardial perfusion tomography at baseline and after nitrate administration, using a 2-day protocol, and rest-reinjection thallium-201 single-photon emission tomography (SPET) studies in order to assess whether nitrates enhance the detection of viable myocardium with99mTc-tetrofosmin. Fifteen patients with coronary artery disease, previous myocardial infarction and a left ventricular ejection fraction <40% underwent201T1 rest-injection and99mTc-tetrofosmin. baseline-postnitroglycerin (0.4 mg sublingually) SPET studies, within 48 h. Tomograms based on the three spatial planes were divided into 15 segments and regional tracer uptake was quantitatively analysed. Viability was defined as presence of tracer uptake >50% of peak activity on baseline studies or after reversibility. The percentage of peak activity of99mTc-tetrofosmin at baseline correlated with that of 201T1 (r=0.82,P <0.001). On baseline99mTc-tetrofosmin studies, 73 of the 225 segments that were analysed had <50% of peal. activity. Fifteen percent of these segments showed reversibility after nitrate administration, with an increase in99mTc-tetrofosmin uptake from 40%±9% to 57%±9% of peak activity (P=0.003). All reversible segments after nitrate administration had viability criteria on201Tl studies, but 20 segments that were non-viable on99mTc-tetrofosmin. studies were viable on201Tl studies. Using a threshold value of >40% of peak activity, only seven segments remained non-viable on99mTc-tetrofosmin studies. Overall agreement between99mTc-tetrofosmin with nitrates and201Tl-reinjection regarding the presence of myocardial viability was 90%. Detection of myocardial viability with99mTc-tetrofosmin. was enhanced after nitrate administration, correlating with viability criteria observed on thallium studies. 相似文献
47.
48.
49.
50.
Ana Velasco Victor Palomar-Asenjo Laura Ga?an Lluis Catasus Nuria Llecha Angel Panizo Victor Palomar-Garcia Miquel Quer Xavier Matias-Guiu 《Diagnostic molecular pathology》2005,14(2):109-114
The familial paraganglioma syndrome is an autosomal dominant disorder characterized by the presence of carotid body paragangliomas and, less frequently, paragangliomas of the glomus jugulare, glomus vagale, and adrenal pheochromocytomas. Germline mutations of the genes for succinate dehydrogenase subunits D, B, or C (SDHD, SDHB, SDHC) have been identified in some kindreds with familial paraganglioma. In this study, we report the clinicopathologic features of four different kindreds with familial paraganglioma, which were screened for germline mutations in the SDHD gene. DNA was obtained from tumor and normal tissue, as well as from peripheral blood. Mutation analysis was performed by single-strand conformation polymorphism analysis and DNA sequencing. SDHD germline mutations were detected in the affected family members of the four families, as well as in several asymptomatic carriers. An identical mutation in exon 4 of SDHD (334-337delACTG) was identified in two apparently unrelated kindreds. The third family showed a germline mutation in exon 2 (W43X). The mutations present in these three families had been previously described in Spanish families, suggesting a founder effect. The fourth family exhibited a mutation in exon 2 of SDHD (170-171delTT), which had not been previously identified. The affected family members of the four kindreds showed paragangliomas, located in the head and neck region, and all of them were benign. These results confirm that genetic testing of SDHD may be a powerful tool for the identification of the syndrome in patients with multiple or bilateral paragangliomas. 相似文献